ranimustine has been researched along with Neurofibromatosis 1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirato, J; Kamiya, M; Kurachi, H; Nakazato, Y; Sasaki, A; Yokoo, H | 1 |
1 other study(ies) available for ranimustine and Neurofibromatosis 1
Article | Year |
---|---|
Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression.
Topics: Adolescent; Antigens, Nuclear; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biomarkers, Tumor; Cerebral Ventricle Neoplasms; DNA Primers; DNA, Neoplasm; Fatal Outcome; Female; Humans; Microfilament Proteins; Muscle Proteins; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Neurofibromatosis 1; Nitrosourea Compounds; Nuclear Proteins; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Procarbazine; Radiography; Thalamus; Tumor Suppressor Protein p53; Vincristine | 2001 |